Latest filing published 12 Mar 2010 for Biocryst Pharmaceuticals INC, €1,307.
Insider track record
No signal scores available.
Mike Mills: trading record in brief
Mike Mills discloses dealings in Biocryst Pharmaceuticals Inc to SEC (Form 4). In total, 8 filings cover trades dated from 17 July 2009 to 12 March 2010.
Every open-market trade on record is a sale: 4 sales worth €47k. Other entries cover 4 option exercises. 2010 to date brings no purchases and 2 sales.
Most recently, on 12 March 2010, the filings show an option exercise worth €1,307 in Biocryst Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mike Mills
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$1.20Common StockSEC:0001127602-10-008533:0
- 1,500 shares@ US$7.31Common StockSEC:0001127602-10-008533:1
- 4,000 shares@ US$4.34Common StockSEC:0001127602-10-004367:0
- 1,146 shares@ US$3.26Common StockSEC:0001127602-10-004367:1
- 5,146 shares@ US$7.05Common StockSEC:0001127602-10-004367:2
- 1,500 shares@ US$3.26Common StockSEC:0001127602-09-016055:0
- 1,500 shares@ US$8.26Common StockSEC:0001127602-09-016055:1
- 968 shares@ US$6.00Common StockSEC:0001127602-09-015822:0
8 of 8 declarations
